New five year clinical trial results have demonstrated the high efficacy and long-term response rates of Metvix® photodynamic therapy (MAL-PDT) in NMSC compared to current standard treatments ...

Please provide your email address to receive an email when new articles are posted on . The overall cure rate among patients that used Metvix following curettage was 90.3%. Adverse events were ...

Dec. 20, 2005 — The European Commission has approved a new indication for topical methylaminolevulinate cream in combination with photodynamic therapy, allowing its use for the treatment of Bowen's ...

PhotoCure ASA's efforts to obtain U.S. approval for its Metvix photodynamic therapy as a treatment for basal-cell carcinoma hit another roadblock last week, as FDA officials ruled that the clinical ...

* Analysis confirmed that photodynamic therapy (PDT) with Ameluz had a lower lesion recurrence rate at 12 months compared to pdt with comparator Metvix * Treatment with Ameluz also resulted in an ...

Biofrontera AG (FSE: B8F), the specialist for the treatment of sun-induced skin cancer, today announced detailed results from its Phase III clinical trial evaluating the safety and efficacy of its ...